4//SEC Filing
Alafi Christopher D 4
Accession 0001209191-20-050301
CIK 0001567514other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 5:03 PM ET
Size
8.2 KB
Accession
0001209191-20-050301
Insider Transaction Report
Form 4
Alafi Christopher D
Director10% Owner
Transactions
- Purchase
Common Stock
2020-09-14$29.60/sh+49,500$1,465,200→ 4,743,770 total(indirect: By LLC)
Holdings
- 503,753(indirect: By Trust)
Common Stock
- 170,000(indirect: By Trust)
Common Stock
- 345,223
Common Stock
Footnotes (4)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $29.17 to $29.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F2]Dr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Dr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.
- [F3]Dr. Alafi is the Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.
- [F4]Shireen Michele Alafi is the Trustee of the Christopher D Alafi Family Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001299430
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 5:03 PM ET
- Size
- 8.2 KB